Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study)
ET remains the most used first-line treatment in Brazil. However, access to therapies varies significantly between public and private healthcare sectors. This disparity highlights inequality in access to treatment.
Authors
- Maiane Maria Pauletto (ORCID: https://orcid.org/0000-0002-7743-9498)
- Poliana Signorini
- Tomás Reinert
- Fernando Castilho Venero
- José Bines (ORCID: https://orcid.org/0000-0003-2465-8854)
- Rafaela Gomes de Jesus (ORCID: https://orcid.org/0000-0001-6912-2995)
- Luiza Nardin Weis (ORCID: https://orcid.org/0000-0002-8134-8062)
- Jorge Henrique Santos Leal
- Eduardo Cronemberger (ORCID: https://orcid.org/0000-0001-8493-7287)
- Daniela Dornelles Rosa (ORCID: https://orcid.org/0000-0002-6196-1919)
- Aline Bomfim Vieira (ORCID: https://orcid.org/0000-0002-2479-6774)
- Miguel Guimarães (ORCID: https://orcid.org/0000-0003-3628-7587)
- Heloísa Resende (ORCID: https://orcid.org/0000-0003-4692-3743)
- Tatiana Correa (ORCID: https://orcid.org/0000-0002-3842-8972)
- Juliana Góes Martins Fagundes
- Gustavo Gössling (ORCID: https://orcid.org/0000-0002-4361-2889)
- Romualdo Barroso‐Sousa (ORCID: https://orcid.org/0000-0002-1825-9876)
- Ana Oliveira (ORCID: https://orcid.org/0000-0002-9834-3436)
- Luísa Mostardeiro Tabajara Franche
- Gustavo Werutsky
- José Márcio Barros de Figueiredo
- Marina Musse Bernardes (ORCID: https://orcid.org/0000-0002-1864-108X)
Institutions
- Instituto Nacional de Pesquisas da Amazônia (BR)
- MedSIR (Spain) (ES)
- Instituto do Cérebro de Brasília (BR)
- Instituto de Oncologia do Paraná (BR)
- Instituto de Neurologia de Curitiba (BR)
- Centro de Pesquisas Oncológicas (BR)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Publication Details
- Journal
- Clinical Breast Cancer
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.clbc.2025.05.020
- Citations
- 2
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 3.04